Category: News
-
Webinar: How do Oncologists in LMICs Make Treatment Decisions?
How do oncologists in LMICs like India make treatment decisions? Join our expert panel as we discuss the role of quality of evidence, magnitude of benefit, drug prices, FDA Approval status and clinical practice guidelines in treatment decision making. Discussions will be based on our recent publications in the BMJ Oncology, and ESMO Open. Meeting…
-
ESMO 2025 Highlights & Analysis with Dr. Bishal Gyawali
October 23, 2025 – ecancer published its 10th annual ESMO Congress recap with Dr. Bishal Gyawali. In this video, Dr. Gyawali shares insights on the most noteworthy items to come out of the 2025 ESMO Congress in Berlin, Germany. Highlights include:
-
Dr. Bishal Gyawali speaks with CBC News about Ontario’s new funding program to expedite access to cancer drugs
Dr. Bishal Gyawali spoke with CBC News about Ontario’s new Funding Accelerated for Specific Treatments (FAST) program to expedite access to cancer drugs. Listen via the podcast or read the article. While faster access is welcome, Dr. Gyawali has highlighted several important considerations. The pilot program will apply to 7-10 drugs per year for 3…
-
24th WHO Essential Medicines List Released
The 24th version of the World Health Organization’s (WHO) List of Essential Medicines (EML) and the 10th version of the WHO List of Essential Medicines for Children (EMLc) were released on September 5th, 2025. The WHO EML and EMLc are updated every two years and contain medicines that are considered to be the most safe…
-
Anita Gyawali-Ganesh Gyawali Health Research Award 2025
We are delighted to present the Anita Gyawali-Ganesh Gyawali Health Research Award to Dr. Nitesh Kumar Karna. Dr. Nitesh Kumar Karna is a 3rd-year medical student from BPKIHS, whose research has been accepted as an oral abstract presentation at the prestigious European Society for Medical Oncology (ESMO) Congress 2025 in Berlin, Germany. The award was…
-
Dr. Bishal Gyawali Receives the 2024 William E. Rawls Prize
Dr. Bishal Gyawali was announced as one of the 2024 Canadian Cancer Society Awards for Excellence recipients. He received the 2024 William E. Rawls Prize for outstanding achievements in cancer control research (early career). The William E. Rawls Prize recognizes early-career investigators whose work has provided significant and importance advancements in cancer control. This award…
-
Challenging the Status Quo: Dr. Bishal Gyawali’s Mission to Reform Global Cancer Care
This article was originally published on Queen’s Oncology by Rianna Lewis and is reprinted here with permission. In the high-stakes world of oncology, where innovation often equates to new treatments and big pharmaceutical investments, Dr. Bishal Gyawali has gained recognition by asking a deceptively simple question: Is this actually helping the patient? A medical oncologist…
-
Will you be in Chicago for 2025 ASCO Meeting? Dr. Gyawali will be!
The 2025 Annual ASCO Meeting will be held from May 30th to June 3rd this year in Chicago. The Annual ASCO Meeting gathers inspirational oncologists, researchers, and patient advocates in the cancer field to connect and discuss cutting-edge research and clinical practice. This year on May 30th, Dr. Gyawali will be speaking at the pre-ASCO…
-
Dr. Gyawali Receives the 2025 Yvonne Award for Challenging the Status Quo
The Yvonne Award symbolizes strength and resilience with its unique Y-shaped sculpture, and recognizes young innovators and leaders for their achievements in advancing cancer care. Dr. Gyawali received the Award in the category of ‘Challenging the Status Quo’ out of over 160 nominations globally. This Award reflects Dr. Gyawali’s ongoing effort to advance cancer care…
-
Dr. Gyawali is Named Top 40 Under 40 in Cancer
Out of over 3000 nominations, Dr. Bishal Gyawali is being recognized as one of the 2025 40 Under 40 in Cancer awardees, and is the only awardee based at a Canadian Institution. The Association for Value-Based Cancer Care recognizes emerging leaders with this award for their exemplary contributions to the cancer research field. This prestigious…
